Oppenheimer & CO Inc Trans Medics Group, Inc. Transaction History
Oppenheimer & CO Inc
- $6.18 Billion
- Q2 2024
A detailed history of Oppenheimer & CO Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 42,145 shares of TMDX stock, worth $6.09 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
42,145
Previous 26,570
58.62%
Holding current value
$6.09 Million
Previous $1.96 Million
223.17%
% of portfolio
0.1%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding TMDX
# of Institutions
358Shares Held
29.6MCall Options Held
399KPut Options Held
154K-
Black Rock Inc. New York, NY2.65MShares$382 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$365 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.49MShares$215 Million2.41% of portfolio
-
Invesco Ltd. Atlanta, GA1.36MShares$197 Million0.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.15MShares$166 Million3.04% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.6B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...